REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-RezLondon Stock Exchange·2 days ago, 05:06 AMGSK-2.16%03692-3.52%
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?benzinga_article·Jul 24 at 05:25 AMAMPH-0.97%ANIP-1.65%
Haisen Pharm released its performance for the first three quarters, with a net profit attributable to the parent company of 88.2096 million yuan, an increase of 1.45%Zhitong·Oct 21, 2025 at 03:58 AM001367-2.67%
Haisen Pharm: Net profit of 60.7942 million yuan in the first half of 2025, a year-on-year increase of 4.74%Zhitong·Aug 14, 2025 at 05:42 AM001367-2.67%
The generic drug consistency evaluation sector has declined in the short term, with Guilin Sanjin falling over 6%Zhitong·Aug 5, 2025 at 08:52 PM002275+0.38%300199-2.13%
Haisen Pharm General Manager Ai Lin plans to reduce holdings of no more than 0.97% of sharesZhitong·May 29, 2025 at 06:35 AM001367-2.67%
Haisen Pharm plans to distribute RMB 1.7 for every 10 shares and convert it into 4.8 shares, with the ex-dividend date on May 20, 2024Zhitong·May 12, 2025 at 03:53 AM001367-2.67%
The concept of high stock splits was active in the morning session, with stocks like Kobalt and others hitting the daily limitZhitong·Apr 22, 2025 at 08:48 PM001367-2.67%301252-2.35%
Haisen Pharm released its 2024 annual performance, with a net profit attributable to the parent company of 123 million yuan, an increase of 17.09%Zhitong·Mar 27, 2025 at 10:01 AM001367-2.67%
